BRI2 Interacts with BACE1 and Regulates Its Cellular Levels by Promoting its Degradation and Reducing Its mRNA Levels
Journal:
Current Alzheimer Research
Volume:
10
Page:
532-541
Author(s):
Maria Tsachaki, Angeliki Fotinopoulou, Nefeli Slavi, Vasiliki Zarkou, Jorge Ghiso and Spiros Efthimiopoulos
Functionalized Mesoporous Silica Nanoparticles: A Possible Strategy to Target Cancer Cells Reducing Peripheral Nervous System Uptake
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
2589-2600
Author(s):
C. Ceresa, G. Nicolini, R. Rigolio, M. Bossi, L. Pasqua and G. Cavaletti
Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
4131-4139
Author(s):
Tomoaki Tanaka, Tatsuya Nakatani and Tetsu Kamitani
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
4025-4038
Author(s):
Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou
The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Journal:
Current Topics in Medicinal Chemistry
Volume:
13
Page:
1098-1126
Author(s):
Amit K. Halder, Achintya Saha and Tarun Jha
Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
444-459
Author(s):
Masaki Shiota, Akira Yokomizo, Naohiro Fujimoto, Hidetoshi Kuruma and Seiji Naito
The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
411-422
Author(s):
Krithi Rao-Bindal, Nadezhda V. Koshkina, John Stewart and Eugenie S. Kleinerman
An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
11
Page:
118-136
Author(s):
Rekha Jain, Vinayak Pachapur, Aditi Kapoor, Meghana S. Vasavada, Prateek Singh, Durairaj Renu, Jyoti Bajpai Dikshit and Sanjeeva Srivastava
Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
13
Page:
1166-1176
Author(s):
Liping Deng, Jian Dong and Wei Wang
Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
12
Page:
117-128
Author(s):
Qian-sheng Yu, Marcella Reale, Mohammad A. Kamal, Harold W. Holloway, Weiming Luo, Kumar Sambamurti, Balmiki Ray, Debomoy K. Lahiri, Jack T. Rogers and Nigel H. Greig